-Live Mint Cipla Ltd won a landmark patent case against Swiss drug maker F Hoffmann-La Roche Ltd in the Delhi high court on Friday over the Indian company’s generic copy of lung cancer drug Tarceva after a four-year court battle. Justice Manmohan Singh observed in his 280-page judgement that it had been scientifically proven that Cipla’s generic version was a polymorph B variant of Roche’s patented drug and that it didn’t actually...

-The Hindu Shankar’s cartoon on Ambedkar and the Constitution has been discussed threadbare by now. The Thorat committee report has added more layers to the controversy. I would like to contribute to the ongoing debate in a different way — through more cartoons. Like most other contemporary issues in India, especially those related to identity and caste politics, this one too has conveniently assumed a complex, fudged nature, giving rise to three...

-The Economic Times PUNE: Ravindra Daftari, chairman , Daftari Agro, said, "We used to sell 2,000 packets of desi seeds. But this year, sales went up to 9,000 packets. Next year, we plan to increase the production of desi seeds by four times."  Mahabeej, the Maharashtra government's seed corporation, has undertaken a programme with Punjabrao Deshmukh Krishi Vidyapeeth (PKV), Akola, to increase the production of desi cotton seeds from 200 quintals this...

-Reuters World food prices dropped in May for a second month in a row, hit by steep falls in dairy products, sugar and other commodities, and are likely to fall further in the coming months, the United Nations' Food and Agriculture Organisation (FAO) said on Thursday. Food prices grabbed attention of the world leaders after their spike to record highs in February 2011 helped fuel the protests known as the Arab Spring...

-PTI A whopping 70% of maladies in India are waterborne owing to poor water quality: study Water purifier market in India is likely to touch Rs 7,000 crore by 2015 from the current level of about Rs 3,200 crore, an Assocham study has said. Water purifier segment in India is growing at a compounded annual growth rate of about 25% and is largely driven by rising sales of low-cost variants triggered by...